Dennis Partners has been tracking Regulatory job posting data for small to medium-sized biopharma companies for the past few years. We often look at this data to spot trends in Regulatory hiring which may be helpful for both hiring managers and regulatory professionals. As biopharma companies struggle to hire and retain Regulatory talent, the debate[…]
Given the recent layoffs within the bio/pharma industry, it may appear companies have regained the advantage in what has largely been a candidate-driven market over the last several years, but the writing on the wall shows that may not be true. A recent HR Dive article Return to office might be making workers miserable indicates[…]
Dennis Partners conducted our third-annual survey on Regulatory Career Motivations during the week of February 20, 2023. Since the start of The Great Resignation in 2021, a record number of employees have left their positions for new ones. A recent LinkedIn survey estimates as many as 70% of employees are still considering changing jobs this[…]
Pay transparency is coming to the biopharma industry. In fact, there’s already some form of law in place in California, Colorado, Connecticut, Maryland, and Washington with new transparency laws enacting in New York on November 1, 2022. Job boards such as Indeed are seeing an increase in companies sharing salary ranges. LinkedIn’s latest Workforce Confidence[…]
This is our Regulatory Landscape newsletter for July 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of June, there were over 100 new Regulatory roles posted as smaller and mid-sized biotech and pharma companies. This is down a bit from May but in line with what we saw[…]
In today’s market, it’s incredibly challenging to find the desired Regulatory talent for growing bio/pharma organizations. We’ve seen companies adjust levels, rapidly promote people, and lower their expectations. It’s an arduous process but once you finally are ready to make an offer, it’s becoming increasingly difficult to get the acceptance. The biggest challenge is that[…]
Dennis Partners conducted a survey in June 2021 to determine if and how The Great Resignation was impacting Regulatory Affairs professionals and their motivations to stay in their current position or seek a new one (survey results here). In order to better understand how Regulatory professionals are feeling about the current job market in 2022,[…]
Nearly two years into the pandemic-driven shift in how (and where) we work, employees have made it abundantly clear that they are seeking greater flexibility and autonomy from their employers – and they’re finally getting it. The ability to work some days at home and some days in the office (a hybrid model) or working[…]
Companies across the US are all too familiar with current hiring challenges: too many open roles and not enough qualified candidates. Fueled by “the Great Resignation” and a pandemic-era shift in priorities, along with a surge of new biotech companies and record IPOs, Regulatory Affairs job openings are at an all-time high. We are seeing[…]
This is our July 2021 Regulatory Landscape newsletter with monthly insights on the evolving market for regulatory professionals. In June we saw over 150 new Regulatory roles at smaller and mid-sized biotech and pharma companies. This doesn’t include Regulatory positions at Big Pharma companies, Medical Device or Diagnostics firms. As usual, most of these were[…]
